The future of the global concussion market looks promising with opportunities in the hospital & clinic and diagnostic center markets. The global concussion market is expected to reach an estimated $9.78 billion by 2030 with a CAGR of 3.9% from 2024 to 2030. The major drivers for this market are rising number of injuries from sports and road accidents, increasing aging population, and growing research and development activities across the globe.
Some of the key questions
answered in this exclusive report are:
Q.1. What are some of
the most promising, high-growth opportunities for the concussion market by type
(diagnosis and treatment), end use (hospitals and clinics, diagnostic centers,
and others), and region (North America, Europe, Asia Pacific, and the Rest of
the World)?
Q.2. Which segments will
grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and
why?
Q.4. What are the key
factors affecting market dynamics? What are the key challenges and business
risks in this market?
Q.5. What are the
business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market
and the reasons behind them?
Q.7. What are some of
the changing demands of customers in the market?
Q.8. What are the new
developments in the market? Which companies are leading these developments?
Q.9. Who are the major
players in this market? What strategic initiatives are key players pursuing for
business growth?
Q.10. What are some of
the competing products in this market and how big of a threat do they pose for
loss of market share by material or product substitution?
Q.11. What M&A
activity has occurred in the last 5 years and what has its impact been on the
industry?
Market Segmentation:
In this market,
diagnosis and treatment are the major segments of concussion market by type
Lucintel forecasts that diagnosis is expected to witness higher growth over the
forecast period due to growing number of brain injury cases across the globe.
Within this market,
hospitals & clinics will remain the largest segment due to avialability of
advanced medical equipment and favorable reimbursement facilities and
increasing preference of people towards hospitals as a preffered mode of treatment.
North America is
expected to witness highest growth over the forecast period due to the rising
incidence of concussions stemming from brain injuries along with increasing
awareness efforts by government organizations and private firms.
Zydus Cadila, Novartis,
Lupin, Mylan, Medtronic, Pfizer, Sanofi, InfraScan, Oculogica, Raumedic, and
BioDirection are the major suppliers in the concussion market.
About
Lucintel
Lucintel, the premier global
management consulting and market research firm, creates winning strategies for
growth. It offers market assessments, competitive analysis, opportunity
analysis, growth
consulting, M&A, and due diligence services to executives and
key decision-makers in a variety of industries.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056
Related Reports
1. Pharmaceutical Contract Manufacturing Market
3. Stent Market
5. 3D
Printing Medical Device Market
8. Medical Lifting Sling
Market
No comments:
Post a Comment